Symptoms that are linked to psychosis are also experienced by individuals who are not in need of care. In the present study, cortical thickness was investigated in these individuals. Fifty individuals with non-clinical auditory verbal hallucinations (most of them also experienced other non-clinical psychotic symptoms), 50 patients with a psychotic disorder and auditory verbal hallucinations, and 50 healthy control subjects underwent structural magnetic resonance imaging. Data were analysed using FreeSurfer. Cortical thickness in the pars orbitalis, paracentral lobule, fusiform gyrus and inferior temporal gyrus was lowest in patients, intermediate in the non-clinical hallucinating group, and highest in control subjects. The patients also showed thinning in widespread additional areas compared to the two other groups, whereas both hallucinating groups showed similar levels of thinning in the insula. Ranking the levels of cortical thickness per brain region across groups revealed that for 88% of brain regions, cortical thickness was lowest in patients, intermediate in the non-clinical hallucinating group, and highest in controls. These findings show that individuals with non-clinical psychotic symptoms show a similar but less pronounced pattern of cortical thinning as patients with a psychotic disorder, which is suggestive of a similar, but milder underlying pathophysiology in this group compared to the psychosis group.
Introduction
Psychotic disorders have consistently been associated with widespread cortical thinning, starting early in the disease (Narr et al., 2005) . Structural neuroimaging studies investigating individuals who take an intermediate position on the continuum have focused on schizotypal personality disorder, which shares similarities in genetics, phenomenology and neurochemistry with schizophrenia, but is associated with milder symptoms (Siever and Davis, 2004; Hazlett et al., 2012; Asami et al., 2013) . One of those studies analysed whole-brain volume and included both schizophrenia and healthy control groups, offering the possibility to directly compare grey matter volume to the two groups at opposite ends of the spectrum. This study showed grey matter reductions in patients with schizotypal personality disorder that were less pronounced than in schizophrenia (Kawasaki et al., 2004) . However, schizotypal patients in this study used antipsychotic medication. Moreover, schizotypal patients function less well in society than healthy people, such as having a passive lifestyle with few social interactions (Raine et al., 2002) . As such, grey matter reductions in this group could stem from these confounding factors.
In the continuum, non-clinical individuals with auditory verbal hallucinations (AVH), who function within normal limits, are located more towards the healthy side of the spectrum compared to patients with schizotypal personality disorder (Sommer et al., 2010a) . In recent studies by our group, we showed that next to neutral and benign AVH, these individuals present with additional non-clinical psychotic symptoms such as an increased level of suspicion, a tendency for magical ideation, and an elevated level of formal thought disorder compared to controls (Sommer et al., 2010a, b; Daalman et al., 2011) . In addition, they have an increase in the number of family members with psychotic symptoms compared to controls (Sommer et al., 2010a) . Importantly, these individuals do not fulfil criteria for schizotypal personality disorder as they function well on both a professional and on a social level, as witnessed by a high global assessment of functioning score, which indicates that these individuals are socially effective, generally satisfied with life and interested and involved in a wide range of activities (Sommer et al., 2010a) .
The aim of the present study was to clarify the nature of potential neuroanatomical differences in cortical grey matter in individuals with non-clinical AVH compared to both patients with a full-blown psychotic disorder and AVH, and healthy controls in a whole-brain approach. Based on the findings in schizotypal personality disorder, we hypothesized that individuals with non-clinical AVH and patients with clinical psychosis and AVH show some degree of cortical thinning, such that the individuals with non-clinical psychotic symptoms show a similar but less pronounced pattern of cortical thinning as compared to the patients with a psychotic disorder (Narr et al., 2005; Rimol et al., 2012) .
Materials and methods

Subjects
Fifty non-clinical individuals with AVH, 50 patients with a psychotic disorder and AVH, and 50 healthy control subjects were matched for age, gender, handedness and years of education of the parents. Demographics and clinical data for all groups are shown in Table 1 .
An extended description of the recruitment and selection procedure of the healthy controls and the non-clinical individuals with AVH is provided in previous studies of our group (Diederen et al., 2010; Sommer et al., 2010a; van Lutterveld et al., 2010 van Lutterveld et al., , 2014 Daalman et al., 2011) . In short, controls subjects and non-clinical individuals with AVH were recruited via a website: www.verkenuwgeest.nl ('explore your mind'). Inclusion criteria were: (i) no current or past psychiatric disorders as assessed by the Comprehensive Assessment of Symptoms and History (CASH) interview and the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-III-R personality disorders (SCID-II) to exclude axis I and axis II pathology (Andreasen et al., 1992; First et al., 1995) . Anxiety or depressive disorder in full remission were not considered exclusion criteria; (ii) no chronic somatic disorder; (iii) absence of alcohol or drug abuse for at least 3 months before the assessments. To confirm the absence of current drug abuse, urine samples were collected and tested for opiates, amphetamines/ Ecstasy (XTC), cocaine and cannabis. Additional inclusion criteria for the nonclinical individuals with AVH consisted of (iv) voices that were distinct from thoughts and had a 'hearing' quality; (v) voices that were experienced at least once a month; and (vi) drug or alcohol abuse did not precede the first experience of AVH. All patients with a psychotic disorder were recruited from the Psychiatry Department of the University Medical Centre Utrecht and the Parnassia Groep in The Hague, The Netherlands. Patients were diagnosed using the CASH interview according to DSM-IV criteria by an independent psychiatrist (Andreasen et al., 1992) . All patients met criteria for schizophrenia (45 participants) or schizo-affective disorder (five participants) and all experienced AVH. Inclusion criteria consisted of: (i) voices were distinct from thoughts and had a 'hearing' quality; and (ii) voices were experienced at least once a month. The study was approved by the Local Ethics Committee of the University Medical Centre Utrecht and was conducted according to the Declaration of Helsinki.
Questionnaires and interviews
Schizotypal traits in the non-clinical individuals with AVH and the healthy controls were assessed using the schizotypal personality questionnaire (Raine, 1991) . In addition, the family interview of genetic studies was used to assess whether controls and non-clinical hallucinating individuals had first or second degree family members with a psychotic or a manic disorder (Maxwell, 1992) . The Positive and Negative Syndrome Scale (PANSS) interview was used to assess symptom severity in patients on the day of scanning (Kay et al., 1987) .
Image acquisition
High-resolution MRI scans were obtained with a 3 T MRI scanner (Philips). T 1 -weighted images were acquired with a 3D T 1 turbo field-echo sequence. The acquisition protocol parameters were: 160 slices; repetition time = 9.96 ms; echo time = 4.59 ms; flip angle 8 ;
1 mm slice thickness with no inter-slice gap; matrix = 256 Â 256 and field of view 224 mm, achieving a voxel size of 0.875 Â 0.875 Â 1 mm. Scan time was 8 min and 50 s.
Image processing
Data were analysed using FreeSurfer version 5.1.0 (http://surfer.nmr. mgh.harvard.edu). In the present study, regional measures of cortical thickness were obtained from the automated anatomic parcellation procedure (Fischl, 2012) . In brief, images underwent preprocessing steps including intensity normalization, skull stripping, Talairach transformation, and assignment of neuro-anatomical labels to each voxel using a probabilistic atlas. In this way, 34 distinct cortical regions were segmented for each hemisphere (Desikan et al., 2006) .
Statistics Cortical thickness
Statistical testing for differences in cortical thickness across groups was conducted by performing ANCOVA with between factor 'group' (nonclinical individuals with AVH, patients with a psychotic disorder and controls) for each brain region. Age and gender were entered as covariates to increase power of the statistical tests (Barnes et al., 2010) . The Bonferroni procedure was used to correct for multiple comparisons at a significance threshold of P 5 0.05. For brain regions that survived this adjustment, the least-square difference test was used for post hoc analyses across groups. Fisher's least-square difference test preserves the experimental type I error rate at the omnibus test level of significance only if the number of groups is three (Meier, 2006) . For regions in which the non-clinical individuals with AVH showed significant differences in cortical thickness compared to controls, the number of non-clinical individuals with AVH and the number of patients with a psychotic disorder and AVH that fell outside one standard deviation (SD) around the control group mean were assessed. Antipsychotic medication (none/typical/atypical/both) 0 4/11/ 34/1 0 SPQ = Schizotypal Personality Questionnaire; NOS = not otherwise specified; GAF = global assessment of functioning. Number of cases with missing data: SPQ controls: n = 3; SPQ non-clinical individuals with AVH: n = 1; years of education controls: n = 1; years of education patients: n = 2; years of education father controls: n = 2; years of education father non-clinical individuals with AVH: n = 2; years of education father patients: n = 12; years of education mother controls: n = 2; years of education mother non-clinical individuals with AVH: n = 1; years of education mother patients: n = 10; PANSS scores patients: n = 6. GAF score controls: n = 2; GAF score patients: n = 1; first or second degree family members with a psychotic disordercontrols: n = 4; first or second degree family members with a psychotic disorder non-clinical individuals with AVH: n = 3. First or second degree family members with a manic disorder controls: n = 4; first or second degree family members with a manic disorder non-clinical individuals with AVH: n = 3. a Mean and (standard deviation) are reported unless otherwise specified. b Differences in handedness, gender and relatives with a psychotic disorder were tested using the chi-square test. As the assumptions of the chi-square omnibus test did not hold for ethnicity and relatives with a manic disorder, these variables were tested using Fisher's exact tests. Differences in continuous data across the three groups were tested using univariate ANOVA. As SPQ scores and duration of hearing voices were only available for two groups, these measures were investigated using an independent samples t-test. 
Rank analysis
A non-parametric analysis was used to assess whether cortical thickness measures in non-clinical individuals with AVH were in between those of controls and patients. The cortical thickness measures of each cortical region were recoded based on the regions' average cortical thickness across the three groups with age and gender regressed out. In this way, there were six possible orders for each cortical region of interest: (i) Controls 4 
Correlations
To assess associations between cortical thickness and clinical measures, partial Pearson's correlation coefficients (controlling for age and gender) were calculated between cortical thickness in each brain region and clinical variables. Detailed information regarding this analysis is provided in the Supplementary material.
Relatives without a psychotic disorder
As the non-clinical group with AVH had a significantly higher number of relatives with a psychotic disorder than the control group, the cortical thickness and rank analysis were repeated after exclusion of non-clinical individuals with AVH and control individuals having relatives with a psychotic disorder. Groups were again matched on age, gender, handedness and years of education of the parents, leading to groups with 37 individuals each.
Results
Questionnaires and interviews
The non-clinical individuals with AVH showed an increase in total Schizotypal Personality Questionnaire score compared with controls [mean non-clinical with AVH: 28.7, SD 12.4; mean controls: 7.6, SD 6.1; t(94) = À 10.640, P 5 0.0005]. The non-clinical individuals with AVH had an increase in the number of first and second degree family members with a psychotic disorder compared with controls [non-clinical with AVH: 10; controls; 1; 2 = 8.134, P = 0.004], whereas no difference in first or second degree relatives with a manic disorder was observed [non-clinical with AVH: 3; controls: 3; Fisher's exact test; P = 1.000] (Table 1) . For the patients with a psychotic disorder, average total PANSS score was 66.4, SD 16.0. Average score on the positive subscale of the PANSS interview was 16.9, SD 4.3, on the negative subscale 17.0, SD 5.0 and on the general subscale 32.5, SD 9.3. Table 2 lists the areas with significant differences in cortical thickness across groups and Fig. 1 provides a graphical representation of these results. Supplementary Table 2 shows average cortical thickness and corresponding P-values of the statistical analysis for all assessed brain regions. Supplementary Table 3 shows the number of non-clinical individuals with AVH and the number of patients with a psychotic disorder and AVH that fall outside 1 SD around the mean cortical thickness of the control group for the areas in which the non-clinical individuals with AVH showed reductions in thickness compared to controls.
Rank analysis
For the majority of brain regions (60 of 68 regions of interest, i.e. 88.2%), the patients with a psychotic disorder and AVH had the lowest average cortical thickness, the controls had the highest cortical thickness and non-clinical individuals with AVH were inbetween. Supplementary Table 4 provides an overview of the observed orders and associated brain regions.
Correlation analysis
There were no significant correlations between cortical thickness and clinical measures after correction for multiple comparisons. The supplementary material shows uncorrected P-values for the non-clinical individuals with AVH and the patients with a psychotic disorder.
Relatives without a psychotic disorder
The Supplementary material shows results from the cortical thickness analysis and the rank analysis in which non-clinical participants with AVH as well as control participants having relatives with a psychotic disorder were excluded.
Discussion
This study compared cortical thickness in non-clinical individuals with AVH, patients with a psychotic disorder and AVH, and healthy controls. In the left paracentral lobule, left pars orbitalis, right fusiform gyrus and right inferior temporal gyrus, patients with a psychotic disorder had the lowest cortical thickness, controls had the highest thickness, and the non-clinical individuals with AVH were in-between. In the right insula, both non-clinical individuals with AVH and patients with a psychotic disorder showed decreased cortical thickness compared with controls. Reductions in cortical thickness in patients versus the two other groups were observed in widespread areas. Ranking the levels of regional cortical thickness across groups revealed that for the large majority of brain regions (88%), the patients had the lowest cortical thickness, the control subjects had the highest cortical thickness and the non-clinical individuals with AVH were in-between.
These results are in-line with our hypothesis that non-clinical individuals with AVH show a similar, but milder pattern of cortical thinning compared to patients with a psychotic disorder. In four of the five areas in which significant reductions in cortical thickness were observed in the non-clinical hallucinating individuals, the patients displayed larger reductions than the non-clinical group. As such, the cortical thickness reductions observed in the non-clinical individuals with AVH may be related to non-clinical psychotic symptoms, whereas more pronounced cortical thinning in these and additional frontal, temporal and parietal areas may be characteristic of patients with a psychotic disorder. In addition, for almost 90% of all analysed regions, cortical thickness in the non-clinical hallucinating individuals was in between that of controls and patients. These findings provide support from a neuroimaging perspective that psychotic symptoms follow a continuum, such that healthy individuals with normal perceptual experiences are at one end of the continuum, individuals with increasingly strong subclinical psychotic symptoms are in-between, and individuals with a psychotic disorder are situated at the opposite end of the spectrum (van Os et al., 2000) .
Limitations
A major consideration is that all non-clinical individuals with AVH and all patients with a psychotic disorder experienced AVH, and as such the former group may not represent subjects with subthreshold psychotic symptoms in general and the latter group patients with a psychotic disorder in general. Also, the majority of participants in the non-clinical group were female. As the psychosis group was matched to the non-clinical group, this was also the case for the psychosis group. As such, the sex ratio of the psychosis group was driven by the non-clinical sample and thus not similar to schizophrenia incidence studies, in which males usually form the majority (McGrath et al., 2004) . A further limitation is that for some variables, such as PANSS and Schizotypal Personality Questionnaire scores, data were not available for all participants. Some of the subjects in the non-clinical group with AVH had relatives with a psychotic disorder. The non-clinical group with AVH represents the spectrum of psychotic symptoms that is close to the healthy side as these individuals function within normal limits. However, they share both genetic and environmental factors with the more severe cases, such as schizotypal and schizophrenic patients (van Os et al., 2010) . These shared risk factors are reflected in the higher family load of clinical cases of psychosis. The presence of some affected family members is inherent to this specific group, as non-clinical psychotic symptoms are a reflection of the increased risk factors. It should furthermore be noted that in patients, antipsychotic medication may have influenced cortical thickness measures, although the exact influence of antipsychotic medication on cortical thinning is not clear yet (Nesvag et al., 2008; Ho et al., 2011) . Another limitation regards the parcellation (region of interest) approach, as abnormalities in a cortical area may not exactly follow the parcellation of the brain in 68 regions of interest. However, the areas showing a reduction in cortical thickness in psychosis compared to controls largely overlap with a recent large study in which cortical thickness was measured along the continuous cortical surface (Rimol et al., 2012) .
In sum, cortical thickness measures for non-clinical individuals with AVH showed a similar, but less pronounced, profile of cortical thinning than patients with a psychotic disorder.
